Table 1.
Baseline characteristics of GALA II participants with methylation data, stratified by ethnicity. Continuous variables are reported with inter-quartile range in brackets.
|
Mexican |
Puerto rican |
Mixed latino |
Other latino |
|
|---|---|---|---|---|
n |
276 |
220 |
16 |
61 |
Males (%) |
125 (45.3%) |
127 (57.7%) |
6 (37.5%) |
28 (45.9%) |
Age |
11.4 [9.3: 14.7] |
12.3 [10.4: 14.2] |
11.8 [10.7: 14.9] |
11.8 [10: 15.7] |
Asthma cases (%) |
124 (44.9%) |
147 (66.8%) |
9 (56.3%) |
31 (50.8%) |
|
Ancestry (n = 524) |
||||
African |
4.3% [2.9%: 6.0%) |
22.8% [16.6%: 29.4%) |
8.5% [5.6%: 19.2%) |
12.3% [6.3%: 25.8%) |
|
Native American |
55.4% [44.5%: 65.7%) |
11.2% [9.8%: 13%) |
31.5% [20.9%: 45.6%) |
32.8% [10.4%: 49.3%) |
European |
40.5% [29.9%: 50.2%) |
65.7% [59.2%: 71%) |
50.5% [44.6%: 57.6%) |
48.9% [40%: 58.5%) |
|
Recruitment Site |
||||
Chicago |
140 (50.7%) |
15 (6.8%) |
11 (68.9%) |
15 (24.6%) |
New York |
18 (6.5%) |
10 (4.5%) |
1 (6.3%) |
23 (37.7%) |
Puerto Rico |
0 |
193 (87.7%) |
0 |
0 |
San Francisco |
78 (28.3%) |
0 |
2 (12.5%) |
23 (37.7%) |
Houston |
40 (14.5%) |
2 (0.9%) |
2 (12.5%) |
5 (8.2%) |
|
Cell Counts (estimated) |
||||
Granulo cytes |
51.2% [46.0%: 55.7%) |
51.6% [46.8%: 57%) |
51% [43.6%: 57.2%) |
49.1% [43.8%: 55.8%) |
Lympho cytes |
41.9% [36.9%: 46.6%) |
41.8% [36.9%: 46.5%) |
41.9% [36.1%: 51.6%) |
43.9% [36.8%: 49.6%) |
Mono cytes |
7.1% [5.8%: 8.3%) |
6.74% [5.74%: 8.24%) |
6.6% [5.7%: 7.6%) |
7.4% [6.2%: 8.6%) |